Daflon. Maka ụkwụ dị arọ, na-egbu mgbu na akwara varicose

Dọkịta nke #1 tụrụ aro, akara na-abụghị ndenye ọgwụ maka ọgwụgwọ mgbaàmà ụkọ venous na-adịghị ala ala. 1

Kedu ka Daflon si arụ ọrụ?

wave icon

Ọgwụgwọ ọgwụgwọ venoactive, dị ka Daflon, ka emebere iji nyere aka melite ahụike akwara ụkwụ anyị site n'ime ka ụda akwara anyị sie ike, nke na-aga n'ihu na-akụda mmụọ ka ụkọ akwara na-adịghị ala ala na-aga n'ihu.

Daflon nwere usoro ihe omume abụọ; bụ mgbochi mkpali edinam venoprotective ozugbo ebelata mgbu na ọzịza; na-echebekwa capillaries ma bụ obere arịa ọbara iji meziwanye microcirculation na ụda venous maka ahụ ike ka mma na ahụ efe nke mgbaàmà dị ka mgbu ụkwụ, na ọzịza. 2

Ọgwụ mgbochi mkpali veinoprotextave edinam nke Daflon na capillaries

Mechie mgbu ụkwụ site n'ime

wave icon

Daflon bụ ọgwụgwọ ọnụ nke egosipụtara, dị irè ma dị mma nke sitere na oroma etobeghị ma bụrụkwa nke a haziri maka nnabata kacha.

Nke a mma absorption pụtara Daflon nwere ike ịbanye na mgbọrọgwụ nke nsogbu ahụ ma na-emeso veins nke ọma n'ime ime ya, na-eme ka ụda olu nke veins dịkwuo mma, nwere ike ichebe ọrịa na-aga n'ihu ma na-enye ahụ efe site na mgbaàmà ụkwụ dị arọ, na-egbu mgbu. 2

Egosiri mmetụta nke Daflon N'ime izu asatọ

4 izu 4

8 izu 4

Ụkwụ mgbu

50%

63%

Mmetụta ịdị arọ

50%

65%

Mmetụta nke ọzịza

50%

63%

Na-ebelata Mgbaàmà

wave icon

Daflon bụ # dọkịta 1 akwadoro, akara na-abụghị ndenye ọgwụ maka ịgwọ mgbaàmà nke ụkọ venous na-adịghị ala ala. 1

Nnyocha ụlọ ọgwụ egosila na Daflon nwere ike ibelata mgbu ụkwụ na mmetụta nke ịdị arọ na ọzịza site na 50% mgbe naanị otu ọnwa ejiri ya. Ọnụ ọgụgụ ndị a dị elu karịa mgbe ọnwa abụọ gachara ọgwụgwọ.

Iji rite uru na ọgwụgwọ Daflon gị, ị kwesịrị ị were ọgwụ gị dịka akwadoro. Jide n'aka na ị ga-enyocha ọnọdụ gị nke ọma ma gwa onye ọkachamara nlekọta ahụike ma ọ bụrụ na ị nwere nchegbu ọ bụla.

Site n'okike, akwadoro nke sayensị.

wave icon

Ihe na-arụ ọrụ na Daflon bụ obere flavonoid dị ọcha nke micronized (MPFF) nke nwere 90% diosmin na 10% flavonoids ndị ọzọ akọwara dị ka hesperidin.

A na-ewepụta flavonoids nke Daflon site na oroma akabeghị aka bụ nke bara ụba na kemịkalụ osisi ndị a na-emekarị. Ogige ndị ahụ na-enweta usoro nke nchacha na nhazi ebe a na-eme ka ihe ndị ahụ na-ejikọta ibe ha na nnukwu ọsọ ọsọ (micronization), na-ebelata ha na obere ihe ndị na-erughị 2 μm n'ogo (micronized). Anụ ahụ na-amịkọrọ obere ihe ndị a ugboro abụọ n'ụzọ dị mfe ma bụrụ isi ihe na-eme ka ihe ịga nke ọma Daflon dị ka ọgwụgwọ maka ịkwalite ahụike akwara na ụda na-adịghị ala ala Venous Insufficiency na Hemorrhoids. 6

Yinye mmepụta nke Daflon bụ obere flavoinoid dị ọcha nke dị ọcha

Ozi nchekwa:

Daflon 500mg Ozi nchekwa

Daflon 500: Micronized, nke dị ọcha flavonoids 500 mg: 450 mg diosmin; 50 mg flavonoids ekwuputara dị ka hesperidine.Ngosipụta ọgwụgwọ nke mgbaàmà nke ọrịa na-adịghị ala ala venous nke ala ụkwụ, ma organic ma ọ bụ arụ ọrụ: mmetụta nke arọ ụkwụ, mgbu, n'abalị cramps. Ọgwụgwọ nke nnukwu hemorrhoidal ngosipụta. Ngwọta na nchịkwa N'ọrịa venous: 1000mg kwa ụbọchị. Na nnukwu ọgụ hemorrhoidal: enwere ike ịbawanye dose ahụ ruo 3000mg kwa ụbọchị.

Mgbochi *

Hypersensitivity na ihe na-arụ ọrụ ma ọ bụ ihe mgbakwunye ọ bụla. Ịdọ aka ná ntị *

Nlekọta ngwaahịa a maka ọgwụgwọ mgbaàmà nke nnukwu hemorrhoid anaghị egbochi ọgwụgwọ maka ọnọdụ gbasara ike ndị ọzọ. Ọ bụrụ na mgbaàmà akwụsịghị ngwa ngwa, a ga-eme nyocha proctological ma nyochaa ọgwụgwọ ahụ. Ihe enyemaka: sodium-free.

INTERACTION(S)* ỤMỤ* Itụrụ ime / LACTATION* Ekwesịrị izere ọgwụgwọ. Ịkwọ ụgbọala & jiri igwe *

MMETỤTA NA-ACHỊGHỊ *

Ihe na-emekarị: afọ ọsịsa, dyspepsia, ọgbụgbọ. Na-adịghị ahụkebe: dizziness, isi ọwụwa, ahụ erughị ala, ihe ọkụ ọkụ, akomuko, urticaria. Ihe na-adịghị ahụkebe: colitis. Amaghi ugboro ugboro: mgbu afọ, ihu dịpụrụ adịpụ, egbugbere ọnụ, edema nkuchianaya. Ọkpụkpọ edema Quincke. Mfefe oke * arịa * ihe nchekwa akwara na venotonic.

[Tradename] na-arụ ọrụ na nlọghachi azụ vaskụla usoro: ọ na-ebelata venous distensibility na venous stasis; N'ime microcirculation, ọ na-eme ka permeability nke capillaries dịkwuo elu ma na-ewusi nguzogide capillary ike. Ngozi *

LES LABORATOIRES SERVIER, 50 rue Carnot, 92284 Suresnes cedex France. www.servier.com *

Maka ozi zuru oke, biko rụtụ aka na nchịkọta njirimara ngwaahịa maka obodo gị.

Daflon 1000mg Ozi nchekwa

Daflon 1000:

Micronized, nke dị ọcha flavonoids 1000 mg: 900 mg diosmin; 100 mg flavonoids ekwuputara dị ka hesperidine.Ngosipụta ọgwụgwọ nke mgbaàmà nke ọrịa na-adịghị ala ala venous nke ala ụkwụ, ma organic ma ọ bụ arụ ọrụ: mmetụta nke arọ ụkwụ, mgbu, n'abalị cramps. Ọgwụgwọ nke nnukwu hemorrhoidal ngosipụta. Ngwọta na nchịkwa N'ọrịa venous: 1000mg kwa ụbọchị. Na nnukwu ọgụ hemorrhoidal: enwere ike ịbawanye dose ahụ ruo 3000mg kwa ụbọchị. Mgbochi *

Hypersensitivity na ihe na-arụ ọrụ ma ọ bụ ihe mgbakwunye ọ bụla. Ịdọ aka ná ntị *

Nlekọta ngwaahịa a maka ọgwụgwọ mgbaàmà nke nnukwu hemorrhoid anaghị egbochi ọgwụgwọ maka ọnọdụ gbasara ike ndị ọzọ. Ọ bụrụ na mgbaàmà akwụsịghị ngwa ngwa, a ga-eme nyocha proctological ma nyochaa ọgwụgwọ ahụ. Ihe enyemaka: sodium-free.

INTERACTION(S)* ỤMỤ* Itụrụ ime / LACTATION* Ekwesịrị izere ọgwụgwọ. Ịkwọ ụgbọala & jiri igwe *

MMETỤTA NA-ACHỊGHỊ *

Ihe na-emekarị: afọ ọsịsa, dyspepsia, ọgbụgbọ, vomiting. Na-adịghị ahụkebe: dizziness, isi ọwụwa, ahụ erughị ala, ihe ọkụ ọkụ, itching, urticaria. Ihe na-adịghị ahụkebe: colitis. Amaghi ugboro ugboro: mgbu afọ, ihu dịpụrụ adịpụ, egbugbere ọnụ, edema nkuchianaya. Ọkpụkpọ edema Quincke. Mfefe oke * arịa * ihe nchekwa akwara na venotonic. [Tradename] na-arụ ọrụ na nlọghachi azụ vaskụla usoro: ọ na-ebelata venous distensibility na venous stasis; N'ime microcirculation, ọ na-eme ka permeability nke capillaries dịkwuo elu ma na-ewusi nguzogide capillary ike. Ngozi *

LES LABORATOIRES SERVIER, 50 rue Carnot, 92284 Suresnes cedex France. www.servier.com *

Maka ozi zuru oke, biko rụtụ aka na nchịkọta njirimara ngwaahịa maka obodo gị.

Ntụaka:

  1.  IQVIA Daflon ahịa data MAT Q2 2021
  2. E nwetara site na Nicolaides A, Kakkos S, Baekgaard N, et al. Nlekọta nke ọrịa venous na-adịghị ala ala nke akụkụ ụkwụ ala. Ntuziaka dịka ihe akaebe sayensị siri dị. Akụkụ I. Int Angiol. 2018;37 (3): 181-254.1
  3. Garner RC, Garner JV, Gregory S, Whattam M, Calam A, Leong D. Ntụle nke absorption nke micronized (Daflon 500 mg) na nonmicronized 14C-diosmin mbadamba mgbe nchịkwa ọnụ na-ahụ ike ọrụ afọ ofufo site accelerator mass spectrometry na mmiri mmiri scintillation. agụta. J Pharm Sci. 2002;91:32-40
  4. Gilly R, Pillion G, Frileux C. Nyochaa nke ọhụrụ venoactive micronized flavonoid fraction (S 5682) na mgbagha mgbaàmà nke mgbasa venolymphatic nke akụkụ ala: ihe ọmụmụ abụọ na-ekpuchi anya, nke na-achịkwa placebo. Phlebology. 1994;9:67-70 .
  5. Pascarella L, Lulic D, Penn AH, et al. Mechanisms na nnwale venous valve ọdịda na mgbanwe ha site na Daflon 500 mg. Ụgwọ nke ụlọ ọrụ Eur J Vasc Endovasc Surg. 2008;35 (1): 102-110 .
  6. Nchịkọta nke njirimara ngwaahịa Daflon

2024